Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab-Reference-Cited by-同舟云学术

Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab

Published:2015-01-12 Issue:4 Volume:50 Page:579-584
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

García-Cadenas I,Castillo N,Martino R,Barba P,Esquirol A,Novelli S,Orti G,Garrido A,Saavedra S,Moreno C,Granell M,Briones J,Brunet S,Navarro F,Ruiz I,Rabella N,Valcárcel D,Sierra J

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2014298.pdf

Reference26 articles.

1. Curtis RE, Travis LB, Rowlings PA, Socié G, Kingma DW, Banks PM et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multiinstitutional study. Blood 1999; 94: 2208–2216.

2. Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 4992–5001.

3. Reddy N, Rezvani K, Barrett AJ, Savani BN . Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders after allogeneic stem cell transplantation in high-risk patients. Biol Blood Marrow Transplant 2011; 17: 591–597.

4. Styczynski J, Reusser P, Einsele H, de la Camara R, Cordonnier C, Ward KN et al. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplant 2009; 43: 757–770.

5. Blaes AH, Cao Q, Wagner JE, Young JA, Weisdorf DJ, Brunstein CG et al. Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation. Biol Blood Marrow Transplant 2010; 16: 287–291.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review;Diagnostic Pathology;2024-09-07

2. EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes;Viruses;2024-08-14

3. Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children;Frontiers in Immunology;2024-07-11

4. Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada;Current Oncology;2024-05-14

5. Viral monitoring in immunocompromised hosts;Molecular Medical Microbiology;2024